NAFT-500

DRUG2 trials

Sponsors

Merz North America, Inc.

Conditions

Athlete's FootJock ItchTinea CrurisTinea Pedis

Phase 3

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris

CompletedNCT00750152

Merz North America, Inc.Jock Itch, Tinea Cruris

Start: 2008-09-30End: 2010-02-28Updated: 2013-04-22

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis

CompletedNCT00750139

Merz North America, Inc.Athlete's Foot, Tinea Pedis

Start: 2008-08-31End: 2009-12-31Updated: 2013-04-26